aluates Reports

$ 0.0

Automative

GLP Analogs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-5M10606

Global and United States GLP Analogs Market Report Forecast 2022 2028

BUY CHAPTERS

GLP Analogs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-5M10606

Report

October 2024

Pages:102

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novo Nordisk

Astrazeneca plc

Eli Lily

GSK

Sanofi

Bristol–Myers Squibb

Amylin

GLP Analogs - Market Size

The global market for GLP Analogs was estimated to be worth US$ 5387 million in 2023 and is forecast to a readjusted size of US$ 7350.9 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030

GLP Analogs - Market

Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.

The Glucagon-like peptide 1 (GLP-1) market is driven by the increasing prevalence of diabetes and the growing demand for effective and innovative diabetes treatments. GLP-1 is a hormone that plays a crucial role in regulating blood sugar levels and is used in the treatment of type 2 diabetes. The rise in the number of diabetic patients and the need for better glycemic control contribute to market growth as GLP-1-based therapies offer significant benefits, including glucose-lowering effects and weight management. Moreover, advancements in GLP-1 analog formulations, such as long-acting and once-weekly options, have improved patient compliance and treatment outcomes. However, the market also faces challenges, including the cost of GLP-1 treatments and the need for further research to optimize dosing and combination therapies. Additionally, addressing the barriers to GLP-1 adoption, such as injection-related fears, can pose obstacles for broader market penetration. To succeed, companies must focus on research and development to offer innovative and cost-effective GLP-1 therapies, collaborate with healthcare providers to optimize treatment regimens, and address the challenges to meet the increasing demand for effective and well-tolerated diabetes treatments based on GLP-1.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GLP Analogs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of GLP Analogs by region & country, by Type, and by Application.

The GLP Analogs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP Analogs.

Market Segmentation

Scope of GLP Analogs - Market Report

Report Metric	Details
Report Name	GLP Analogs - Market
Forecasted market size in 2030	US$ 7350.9 million
CAGR	4.3%
Forecasted years	2024 - 2030
Segment by Type:	Exenatied Liraglutide Lixisenatide Albiglutide Dulaglutide
Segment by Application	Hospital Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Bristol-Myers Squibb, Amylin
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of GLP Analogs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of GLP Analogs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of GLP Analogs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the GLP Analogs - Market size in 2030?

Ans: The GLP Analogs - Market size in 2030 will be US$ 7350.9 million.

Who are the main players in the GLP Analogs - Market report?

Ans: The main players in the GLP Analogs - Market are Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Bristol-Myers Squibb, Amylin

What are the Application segmentation covered in the GLP Analogs - Market report?

Ans: The Applications covered in the GLP Analogs - Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the GLP Analogs - Market report?

Ans: The Types covered in the GLP Analogs - Market report are Exenatied, Liraglutide, Lixisenatide, Albiglutide, Dulaglutide

1 Market Overview

1.1 GLP Analogs Product Introduction

1.2 Global GLP Analogs Market Size Forecast

1.2.1 Global GLP Analogs Sales Value (2019-2030)

1.2.2 Global GLP Analogs Sales Volume (2019-2030)

1.2.3 Global GLP Analogs Sales Price (2019-2030)

1.3 GLP Analogs Market Trends & Drivers

1.3.1 GLP Analogs Industry Trends

1.3.2 GLP Analogs Market Drivers & Opportunity

1.3.3 GLP Analogs Market Challenges

1.3.4 GLP Analogs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global GLP Analogs Players Revenue Ranking (2023)

2.2 Global GLP Analogs Revenue by Company (2019-2024)

2.3 Global GLP Analogs Players Sales Volume Ranking (2023)

2.4 Global GLP Analogs Sales Volume by Company Players (2019-2024)

2.5 Global GLP Analogs Average Price by Company (2019-2024)

2.6 Key Manufacturers GLP Analogs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers GLP Analogs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of GLP Analogs

2.9 GLP Analogs Market Competitive Analysis

2.9.1 GLP Analogs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by GLP Analogs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP Analogs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Exenatied

3.1.2 Liraglutide

3.1.3 Lixisenatide

3.1.4 Albiglutide

3.1.5 Dulaglutide

3.2 Global GLP Analogs Sales Value by Type

3.2.1 Global GLP Analogs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global GLP Analogs Sales Value, by Type (2019-2030)

3.2.3 Global GLP Analogs Sales Value, by Type (%) (2019-2030)

3.3 Global GLP Analogs Sales Volume by Type

3.3.1 Global GLP Analogs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global GLP Analogs Sales Volume, by Type (2019-2030)

3.3.3 Global GLP Analogs Sales Volume, by Type (%) (2019-2030)

3.4 Global GLP Analogs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Pharmacy

4.1.3 Other

4.2 Global GLP Analogs Sales Value by Application

4.2.1 Global GLP Analogs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global GLP Analogs Sales Value, by Application (2019-2030)

4.2.3 Global GLP Analogs Sales Value, by Application (%) (2019-2030)

4.3 Global GLP Analogs Sales Volume by Application

4.3.1 Global GLP Analogs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global GLP Analogs Sales Volume, by Application (2019-2030)

4.3.3 Global GLP Analogs Sales Volume, by Application (%) (2019-2030)

4.4 Global GLP Analogs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global GLP Analogs Sales Value by Region

5.1.1 Global GLP Analogs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global GLP Analogs Sales Value by Region (2019-2024)

5.1.3 Global GLP Analogs Sales Value by Region (2025-2030)

5.1.4 Global GLP Analogs Sales Value by Region (%), (2019-2030)

5.2 Global GLP Analogs Sales Volume by Region

5.2.1 Global GLP Analogs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global GLP Analogs Sales Volume by Region (2019-2024)

5.2.3 Global GLP Analogs Sales Volume by Region (2025-2030)

5.2.4 Global GLP Analogs Sales Volume by Region (%), (2019-2030)

5.3 Global GLP Analogs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America GLP Analogs Sales Value, 2019-2030

5.4.2 North America GLP Analogs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe GLP Analogs Sales Value, 2019-2030

5.5.2 Europe GLP Analogs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific GLP Analogs Sales Value, 2019-2030

5.6.2 Asia Pacific GLP Analogs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America GLP Analogs Sales Value, 2019-2030

5.7.2 South America GLP Analogs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa GLP Analogs Sales Value, 2019-2030

5.8.2 Middle East & Africa GLP Analogs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions GLP Analogs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions GLP Analogs Sales Value

6.2.1 Key Countries/Regions GLP Analogs Sales Value, 2019-2030

6.2.2 Key Countries/Regions GLP Analogs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States GLP Analogs Sales Value, 2019-2030

6.3.2 United States GLP Analogs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States GLP Analogs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe GLP Analogs Sales Value, 2019-2030

6.4.2 Europe GLP Analogs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe GLP Analogs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China GLP Analogs Sales Value, 2019-2030

6.5.2 China GLP Analogs Sales Value by Type (%), 2023 VS 2030

6.5.3 China GLP Analogs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan GLP Analogs Sales Value, 2019-2030

6.6.2 Japan GLP Analogs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan GLP Analogs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea GLP Analogs Sales Value, 2019-2030

6.7.2 South Korea GLP Analogs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea GLP Analogs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia GLP Analogs Sales Value, 2019-2030

6.8.2 Southeast Asia GLP Analogs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia GLP Analogs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India GLP Analogs Sales Value, 2019-2030

6.9.2 India GLP Analogs Sales Value by Type (%), 2023 VS 2030

6.9.3 India GLP Analogs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Novo Nordisk

7.1.1 Novo Nordisk Company Information

7.1.2 Novo Nordisk Introduction and Business Overview

7.1.3 Novo Nordisk GLP Analogs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Novo Nordisk GLP Analogs Product Offerings

7.1.5 Novo Nordisk Recent Development

7.2 AstraZeneca

7.2.1 AstraZeneca Company Information

7.2.2 AstraZeneca Introduction and Business Overview

7.2.3 AstraZeneca GLP Analogs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 AstraZeneca GLP Analogs Product Offerings

7.2.5 AstraZeneca Recent Development

7.3 Eli Lily

7.3.1 Eli Lily Company Information

7.3.2 Eli Lily Introduction and Business Overview

7.3.3 Eli Lily GLP Analogs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Eli Lily GLP Analogs Product Offerings

7.3.5 Eli Lily Recent Development

7.4 GSK

7.4.1 GSK Company Information

7.4.2 GSK Introduction and Business Overview

7.4.3 GSK GLP Analogs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 GSK GLP Analogs Product Offerings

7.4.5 GSK Recent Development

7.5 Sanofi

7.5.1 Sanofi Company Information

7.5.2 Sanofi Introduction and Business Overview

7.5.3 Sanofi GLP Analogs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Sanofi GLP Analogs Product Offerings

7.5.5 Sanofi Recent Development

7.6 Bristol-Myers Squibb

7.6.1 Bristol-Myers Squibb Company Information

7.6.2 Bristol-Myers Squibb Introduction and Business Overview

7.6.3 Bristol-Myers Squibb GLP Analogs Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Bristol-Myers Squibb GLP Analogs Product Offerings

7.6.5 Bristol-Myers Squibb Recent Development

7.7 Amylin

7.7.1 Amylin Company Information

7.7.2 Amylin Introduction and Business Overview

7.7.3 Amylin GLP Analogs Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Amylin GLP Analogs Product Offerings

7.7.5 Amylin Recent Development

8 Industry Chain Analysis

8.1 GLP Analogs Industrial Chain

8.2 GLP Analogs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 GLP Analogs Sales Model

8.5.2 Sales Channel

8.5.3 GLP Analogs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Novo Nordisk

Astrazeneca plc

Eli Lily

GSK

Sanofi

Bristol–Myers Squibb

Amylin

List of Tables

Table 1. GLP Analogs Market Trends

Table 2. GLP Analogs Market Drivers & Opportunity

Table 3. GLP Analogs Market Challenges

Table 4. GLP Analogs Market Restraints

Table 5. Global GLP Analogs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global GLP Analogs Revenue Market Share by Company (2019-2024)

Table 7. Global GLP Analogs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global GLP Analogs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market GLP Analogs Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers GLP Analogs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers GLP Analogs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of GLP Analogs

Table 13. Global GLP Analogs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP Analogs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global GLP Analogs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global GLP Analogs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global GLP Analogs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global GLP Analogs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global GLP Analogs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global GLP Analogs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global GLP Analogs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global GLP Analogs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global GLP Analogs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global GLP Analogs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global GLP Analogs Price by Type (2019-2024) & (USD/Unit)

Table 27. Global GLP Analogs Price by Type (2025-2030) & (USD/Unit)

Table 28. Global GLP Analogs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global GLP Analogs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global GLP Analogs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global GLP Analogs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global GLP Analogs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global GLP Analogs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global GLP Analogs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global GLP Analogs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global GLP Analogs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global GLP Analogs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global GLP Analogs Price by Application (2019-2024) & (USD/Unit)

Table 39. Global GLP Analogs Price by Application (2025-2030) & (USD/Unit)

Table 40. Global GLP Analogs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global GLP Analogs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global GLP Analogs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global GLP Analogs Sales Value by Region (2019-2024) & (%)

Table 44. Global GLP Analogs Sales Value by Region (2025-2030) & (%)

Table 45. Global GLP Analogs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global GLP Analogs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global GLP Analogs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global GLP Analogs Sales Volume by Region (2019-2024) & (%)

Table 49. Global GLP Analogs Sales Volume by Region (2025-2030) & (%)

Table 50. Global GLP Analogs Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global GLP Analogs Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions GLP Analogs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions GLP Analogs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions GLP Analogs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions GLP Analogs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions GLP Analogs Sales Volume, (2025-2030) & (K Units)

Table 57. Novo Nordisk Company Information

Table 58. Novo Nordisk Introduction and Business Overview

Table 59. Novo Nordisk GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Novo Nordisk GLP Analogs Product Offerings

Table 61. Novo Nordisk Recent Development

Table 62. AstraZeneca Company Information

Table 63. AstraZeneca Introduction and Business Overview

Table 64. AstraZeneca GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. AstraZeneca GLP Analogs Product Offerings

Table 66. AstraZeneca Recent Development

Table 67. Eli Lily Company Information

Table 68. Eli Lily Introduction and Business Overview

Table 69. Eli Lily GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Eli Lily GLP Analogs Product Offerings

Table 71. Eli Lily Recent Development

Table 72. GSK Company Information

Table 73. GSK Introduction and Business Overview

Table 74. GSK GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. GSK GLP Analogs Product Offerings

Table 76. GSK Recent Development

Table 77. Sanofi Company Information

Table 78. Sanofi Introduction and Business Overview

Table 79. Sanofi GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Sanofi GLP Analogs Product Offerings

Table 81. Sanofi Recent Development

Table 82. Bristol-Myers Squibb Company Information

Table 83. Bristol-Myers Squibb Introduction and Business Overview

Table 84. Bristol-Myers Squibb GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Bristol-Myers Squibb GLP Analogs Product Offerings

Table 86. Bristol-Myers Squibb Recent Development

Table 87. Amylin Company Information

Table 88. Amylin Introduction and Business Overview

Table 89. Amylin GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Amylin GLP Analogs Product Offerings

Table 91. Amylin Recent Development

Table 92. Key Raw Materials Lists

Table 93. Raw Materials Key Suppliers Lists

Table 94. GLP Analogs Downstream Customers

Table 95. GLP Analogs Distributors List

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. GLP Analogs Product Picture

Figure 2. Global GLP Analogs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global GLP Analogs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global GLP Analogs Sales Volume (2019-2030) & (K Units)

Figure 5. Global GLP Analogs Sales Price (2019-2030) & (USD/Unit)

Figure 6. GLP Analogs Report Years Considered

Figure 7. Global GLP Analogs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global GLP Analogs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by GLP Analogs Revenue in 2023

Figure 10. GLP Analogs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Exenatied Picture

Figure 12. Liraglutide Picture

Figure 13. Lixisenatide Picture

Figure 14. Albiglutide Picture

Figure 15. Dulaglutide Picture

Figure 16. Global GLP Analogs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global GLP Analogs Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global GLP Analogs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 19. Global GLP Analogs Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global GLP Analogs Price by Type (2019-2030) & (USD/Unit)

Figure 21. Product Picture of Hospital

Figure 22. Product Picture of Pharmacy

Figure 23. Product Picture of Other

Figure 24. Global GLP Analogs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global GLP Analogs Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global GLP Analogs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 27. Global GLP Analogs Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global GLP Analogs Price by Application (2019-2030) & (USD/Unit)

Figure 29. North America GLP Analogs Sales Value (2019-2030) & (US$ Million)

Figure 30. North America GLP Analogs Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe GLP Analogs Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe GLP Analogs Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific GLP Analogs Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific GLP Analogs Sales Value by Country (%), 2023 VS 2030

Figure 35. South America GLP Analogs Sales Value (2019-2030) & (US$ Million)

Figure 36. South America GLP Analogs Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa GLP Analogs Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa GLP Analogs Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions GLP Analogs Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions GLP Analogs Sales Volume (%), (2019-2030)

Figure 41. United States GLP Analogs Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States GLP Analogs Sales Value by Type (%), 2023 VS 2030

Figure 43. United States GLP Analogs Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe GLP Analogs Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe GLP Analogs Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe GLP Analogs Sales Value by Application (%), 2023 VS 2030

Figure 47. China GLP Analogs Sales Value, (2019-2030) & (US$ Million)

Figure 48. China GLP Analogs Sales Value by Type (%), 2023 VS 2030

Figure 49. China GLP Analogs Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan GLP Analogs Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan GLP Analogs Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan GLP Analogs Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea GLP Analogs Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea GLP Analogs Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea GLP Analogs Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia GLP Analogs Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia GLP Analogs Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia GLP Analogs Sales Value by Application (%), 2023 VS 2030

Figure 59. India GLP Analogs Sales Value, (2019-2030) & (US$ Million)

Figure 60. India GLP Analogs Sales Value by Type (%), 2023 VS 2030

Figure 61. India GLP Analogs Sales Value by Application (%), 2023 VS 2030

Figure 62. GLP Analogs Industrial Chain

Figure 63. GLP Analogs Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions